4-traders.com, stock quotes, stock exchange, market price, stock market advice, technical analysis, stock chart analysis, Company News
September 3, 2010 11:48 am US/Eastern
Search
Dynamic quotes   
On
 | Off
  • Technical Analysis
  • Market Quotes
  • Market News
  • Market Screeners and Tools

4-Traders Homepage  >  Shares  >  NYSE  >  WATSON PHARM   WPI   US9426831031

WATSON PHARM (WPI)

  
Real time Streaming quotes -
Delayed Quote. Delayed NYSE - 09/03 11:33:08 am
44.36 USD   -1.09%
09/01WATSON PHARM: Watson to Present at the Morgan Stanley Global Healthcare Unplugg..
08/13WATSON PHARM: Watson Plans Q4 2010 ella® (ulipristal acetate) Emergency Contrac..
08/05WATSON PHARM: Watson Q2 Net Revenue Climbs 29 Percent to $875 Million
 SummaryQuotesChart AnalysisNewsCalendarCompanyFundamentalsConsensus
Quotes 5-day view   Delayed Quote. Delayed NYSE - 09/03 11:33:08 am
08/30/2010 08/31/2010 09/01/2010 09/02/2010 09/03/2010 Date
43.25(c) 43.07(c) 44.15(c) 44.85(c) 44.36 Last
1 019 096 1 384 587 1 278 038 1 032 861 416 375 Volume
-1.08% -0.42% +2.51% +1.59% -1.09% Change
More quotes
Fundamentals ($)
Revenue 2010 3 494 M
EBIT 2010 650,1 M
Net Profit 2010 335,9 M
Debt 2010 859,2 M
Yield 2010 -
Revenue 2011 3 914 M
EBIT 2011 735,2 M
Net Profit 2011 388,8 M
Debt 2011 326,3 M
Yield 2011 -
PER 2010 17,09
PER 2011 14,88
VE / Revenue 2010 1,85x
VE / Revenue 2011 1,51x
Capitalization 5 601 M
More Fundamentals
Sector
Pharmaceuticals - Generic / Specialty
Calendar

- Aucun évènement disponible -

Latest news on WATSON PHARM
09/01WATSON PHARM: Watson to Present at the Morgan Stanley Global Healthcare Unplugg..
08/13WATSON PHARM: Watson Plans Q4 2010 ella® (ulipristal acetate) Emergency Contrac..
08/05WATSON PHARM: Watson Q2 Net Revenue Climbs 29 Percent to $875 Million
08/04WATSON PHARM: Watson Names Sigurdur Oli Olafsson Executive Vice President, Glob..
08/03WATSON PHARM: Watson Promotes Robert Stewart to Executive Vice President, Globa..
07/15WATSON PHARM: Watson and Itero Enter Worldwide License Agreement on Biologic De..
07/14WATSON PHARM: Eden Biodesign Assists Momotaro-Gene, Inc. to Commence Human Clin..
07/12WATSON PHARM: Watson Confirms Renvela® for Oral Suspension Patent Challenge
07/08WATSON PHARM: Watson to Host Conference Call and Webcast to Discuss Second Quar..
07/02WATSON PHARM: Watson Completes Acquisition of CRINONE® and PROCHIEVE® Product L..
07/02WATSON PHARM: Watson's Generic Prograf® 5 mg Receives FDA Approval
07/01WATSON PHARM: Watson Launches Generic Exelon®
More news
Chart WATSON PHARM
Short term
Mid-term
Long term
Graphique historique des cours de bourse de WATSON PHARM
Full-screen chart
Trends chart analysis
Short termMid-termLong term
BullishBullishBullish
Chart Analysis
Income Statement Evolution
WATSON PHARM : Income Statement Evolution
More Fundamentals
EPS Reviews
WATSON PHARM : EPS Reviews
More Estimates Reviews
Price share WATSON PHARM (USA), Source for Financial Market Quotes, Charts, Technical Analysis and Consensus. Stock market quotes including the latest stock price , stock market quote for the NASDAQ 100, news and fundamental investing data and price charts. The easy way to get information on stocks, currencies, indexes, commodities , certicates, and Warrants. Contact us ¤ Site map
Quotes are delayed 15 minutes for Nasdaq, Nyse and Euronext. Dow Jones indexes from Dow Jones & Company and Nasdaq indexes are 15 minutes delayed. CAC 40, Forex and Tradegate exchange are in real-time. Others exchanges are in end of day. Data are provided by Interactive Data - Tijd Beursmedia.
Copyright ©  2001 - 2010 Surperformance SAS /